Poster Presentation Melbourne Protein Group Student Symposium 2013

High resolution NMR studies of apical membrane antigen 1 (AMA1), a target for antimalarial drug development (#12)

Krishnarjuna Bankala 1 , San Sui Lim 1 , Christopher MacRaild 1 , Indu Chandrashekharan 1 , Raymond S Norton 1
  1. Monash Institute of Pharmaceutical Sciences, Parkville, VIC, Australia

The malaria antigen apical membrane antigen 1 (AMA1) is a protein of the Plasmodium parasite that is involved in the formation of the moving junction during red blood cell infection (1). Thus, AMA1 has become a target for drug development (2). Here we describe the application of solution NMR spectroscopy to study AMA1-small molecule interactions. Based on perturbations in specific chemical shifts in the NMR spectrum of AMA1, it is feasible to map the binding sites for ligand/small inhibitory molecules, facilitating the design of new drugs to treat malaria.
AMA1 is a high molecular mass (42 kDa) protein, making its chemical shift analysis particularly challenging because of resonance overlap. We have used different labelling approaches including selective unlabelling to simplify and speed up the process of specific resonance assignments (3). The results from chemical shift analysis of AMA1 using selective unlabelling methods and other NMR approaches will be presented.

  1. Tonkin ML, et al. (2011) Host cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptide. Science 333:463-467.
  2. MacRaild CA, Anders RF, Foley M, & Norton RS (2011) Apical membrane antigen 1 as an anti-malarial drug target. Curr. Top. Med. Chem. 11:2039-2047.
  3. Krishnarjuna B, Jaipuria G, Thakur A, D’Silva P, & Atreya HS (2011) Amino acid selective unlabeling for sequence specific resonance assignments in proteins. J. Biomol. NMR 49:39-51.